Biology of Nicotinamide Coenzymes: From Basic Science to Clinical Applications (Hardcover, 2025)

Chapter 1 Overview of nicotinamide coenzymes.-?Chapter 2?Niacin deficiency and discovery of Vitamin B3 as a precursor of the nicotinamide coenzymes.-?Chapter 3 Identification, source and intracellular distribution of nicotinamide coenzyme I.-?Chapter 4?Overview of nicotinamide adenine dinucleotide.-?Chapter 5.-?The synthesis and degradation of NAD+ and methods for enhancing NAD+ levels.- Chapter 6?The role of nicotinamide phosphoribosyl transferase in NAD+ synthesis.-?Chapter 7?Methods for coenzyme I assessment.-?Chapter 8?Sources and cellular distribution of coenzyme II.-?Chapter 9?Physiological functions of nicotinamide coenzyme II.- Chapter 10 Anabolism and catabolism of coenzyme II.-?Chapter 11?Methods for increasing coenzyme II.-?Chapter 12?The function of TIGAR and the synthesis of coenzyme II.-?Chapter 13 The role of glucose 6-phosphate dehydrogenase in generating coenzyme II.-?Chapter 14?Methods for coenzyme II assessment.-?Chapter 15 Interconversion of coenzyme I and II, trans-organelle transport and its significance.-?Chapter 16?Physiological role of nicotinamide coenzyme I in cellular metabolism.-?Chapter 17?Nicotinamide adenine dinucleotide and signaling transduction.- Chapter 18?Nicotinamide adenine dinucleotide and immunoregulation.- Chapter 19?Coenzyme I and biological rhythm.- Chapter 20?Nicotinamide coenzyme II and free radical metabolism and homeostasis.- Chapter 21?Nicotinamide coenzyme II and reductive synthesis, biotransformation, and protein interactions.- Chapter 22?NADPH and purinergic signal transduction.- Chapter 23?Nicotinamide adenine dinucleotide and heart disease.-Chapter 24?Nicotinamide adenine dinucleotide in lipid metabolism and atherosclerosis.- Chapter 25?Nicotinamide adenine dinucleotide and ischemic stroke.- Chapter 26?Nicotinamide adenine dinucleotide and its precursors in hemorrhagic stroke.-Chapter 27?Nicotinamide coenzymes and metabolic diseases.- Chapter 28?Nicotinamide adenine dinucleotide and Aging.-Chapter 29?Coenzyme I and intestinal diseases.-Chapter 30?Coenzyme I and skeletal muscle disorders.- Chapter 31?Coenzyme I and chronic fatigue syndrome.- Chapter 32 Coenzyme I and depression.- Chapter 33?The role of NAD+-dependent signal mechanisms in cancer development and treatment.- Chapter 34?Nicotinamide adenine dinucleotide and Alzheimer disease.- Chapter 35 Nicotinamide adenine dinucleotide and Parkinson disease.- Chapter 36?Coenzyme II and aging.- Chapter 37?Coenzyme II and heart disease.- Chapter 38 Coenzyme II and vascular endothelium and blood-brain barrier.- Chapter 39 NADPH and Alzheimer's disease and Parkinson disease.-Chapter 40?Coenzyme II and ischemic stroke.- Chapter 41?NADPH and neuroinflammation.- Chapter 42?Nicotinamide coenzyme II and neuroexcitotoxicity.- Chapter 43?Inhibition of platelet aggregation and thrombosis by nicotinamide coenzymes.- Chapter 44?Research on the production technology of nicotinamide coenzymes and their precursors.- Chapter 45?Methods for industrial scale preparation and purification of nicotinamide coenzymes and their precursors.- Chapter 46?The application of the nicotinamide coenzymes and precursors.- Chapter 47?The application of nicotinamide coenzyme precursors in health food.- Chapter 48?Coenzyme I Drug.